Desperate patient gets own stem cells for rare nerve disease
NCT ID NCT04064983
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study treated one 58-year-old man with polyneuropathy caused by POEMS syndrome using his own fat-derived stem cells. He received eight infusions over 28 weeks to try to relieve nerve symptoms. The study is no longer available and was not a formal clinical trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous adipose-derived mesenchymal stem cells (HB-adMSCs)
- What this could lead to
- If it works, this could point toward a way to ease nerve pain and weakness in people with POEMS syndrome.
- What could go wrong
- This was a single-patient expanded access study, not a formal trial, so results may not apply to others. The treatment is experimental and risks are not well understood.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYNEUROPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a daily pill keep a rare heart disease in check for the long haul?
- A muscle protein may signal nerve damage in diabetes — study puts it to the test
- Could your age change how a nerve test reads your nerves?
- New ultrasound and DNA test could revolutionize leprosy diagnosis
- AI takes on nerve disease diagnosis: ChatGPT matches specialists?